Gevo (NASDAQ:GEVO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

A number of other analysts also recently issued reports on GEVO. ValuEngine upgraded shares of Gevo from a “hold” rating to a “buy” rating in a report on Monday, April 1st. HC Wainwright set a $10.00 price target on shares of Gevo and gave the company a “buy” rating in a report on Thursday, March 28th.

Shares of NASDAQ GEVO opened at $1.95 on Monday. The firm has a market capitalization of $22.95 million, a price-to-earnings ratio of -0.37 and a beta of 2.78. Gevo has a 52-week low of $1.79 and a 52-week high of $24.74.

Gevo (NASDAQ:GEVO) last announced its quarterly earnings results on Wednesday, May 8th. The energy company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.16). The company had revenue of $6.40 million during the quarter, compared to the consensus estimate of $5.57 million. Gevo had a negative net margin of 101.89% and a negative return on equity of 27.80%. On average, equities research analysts predict that Gevo will post -1.47 earnings per share for the current year.

In other Gevo news, insider Timothy J. Cesarek bought 25,000 shares of Gevo stock in a transaction dated Thursday, June 6th. The shares were purchased at an average cost of $1.91 per share, for a total transaction of $47,750.00. Following the acquisition, the insider now directly owns 30,000 shares in the company, valued at approximately $57,300. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 3.41% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Wedbush Securities Inc. acquired a new position in Gevo during the 1st quarter valued at about $67,000. KBC Group NV boosted its stake in Gevo by 226.3% during the 4th quarter. KBC Group NV now owns 48,033 shares of the energy company’s stock valued at $94,000 after purchasing an additional 33,313 shares during the last quarter. Vanguard Group Inc boosted its stake in Gevo by 596.4% during the 3rd quarter. Vanguard Group Inc now owns 91,617 shares of the energy company’s stock valued at $363,000 after purchasing an additional 78,461 shares during the last quarter. Vanguard Group Inc. boosted its stake in Gevo by 596.4% during the 3rd quarter. Vanguard Group Inc. now owns 91,617 shares of the energy company’s stock valued at $363,000 after purchasing an additional 78,461 shares during the last quarter. Finally, BlackRock Inc. boosted its stake in Gevo by 4,086.6% during the 3rd quarter. BlackRock Inc. now owns 155,072 shares of the energy company’s stock valued at $614,000 after purchasing an additional 151,368 shares during the last quarter. Hedge funds and other institutional investors own 8.55% of the company’s stock.

Gevo Company Profile

Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.

Featured Story: The Discount Rate – What You Need to Know

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.